A Blueprint to Frame, Follow, and Treat the Neuropsychiatric Aspects of Long-COVID-View Presentation

Video Transcription

Video Summary

The session focused on the neuropsychiatric aspects of Long COVID, with experts presenting on their research, findings, and approaches to treatment. Dr. Anita Everett from SAMHSA introduced the session, noting the ongoing impact of COVID-19 and the importance of addressing long-term sequelae. Dr. Jacqueline Becker presented research from Mount Sinai, highlighting cognitive impairments in COVID-19 survivors, and discussed various mechanisms potentially underlying Long COVID symptoms, which remain complex and multifaceted. She emphasized the heterogeneous nature of Long COVID and the challenges in diagnosis and treatment. CJ McKinney from SAMHSA discussed the federal response, highlighting increased funding, services, and research efforts aimed at addressing mental health issues related to Long COVID. He emphasized the importance of a trauma-informed approach and expanding support and resources in underserved communities. Dr. Alexander Yountz from Children's National Hospital shared insights into pediatric Long COVID, describing the symptoms, demographic findings, and multidisciplinary treatment approaches in children. She underscored the need for individualized care and the importance of family and community support in managing long-term effects. The session concluded with a panel discussion, addressing questions on the pathophysiology of Long COVID and the difficulties in providing prognoses due to limited understanding. The experts highlighted ongoing research and potential therapeutic approaches while acknowledging the limitations and need for further studies.

Keywords

Long COVID

neuropsychiatric aspects

cognitive impairments

trauma-informed approach

SAMHSA

Mount Sinai

pediatric Long COVID

mental health

multidisciplinary treatment

federal response

individualized care

pathophysiology